On May, 8 Carrols Restaurant Group, Inc. (TAST) EPS Estimated At $

Mae Love
April 21, 2018

Susquehanna International Group LLP now owns 10,794 shares of the restaurant operator's stock valued at $118,000 after buying an additional 27,358 shares in the last quarter. About 29,351 shares traded. Carrols Restaurant Group has a 52-week low of $9.90 and a 52-week high of $14.45. Wingstop Inc. (NASDAQ:WING) has risen 89.00% since April 21, 2017 and is uptrending. It has underperformed by 30.39% the S&P500. Flanders Paul R also sold $32,000 worth of Carrols Restaurant Group, Inc. Therefore 60% are positive. (NASDAQ:TAST) has 3 ratings reports on April 21, 2018 according to StockzIntelligence. The stock is a Buy among 1 brokerage firms polled by Factset Research. (NYSE:MFA) rating on Friday, November 3. On Tuesday, August 22 the stock rating was maintained by Jefferies with "Hold". The firm earned "Buy" rating on Monday, December 4 by Wells Fargo. 2,176 shares valued at $15,863 were bought by Yarad Stephen D. on Wednesday, February 21. The firm earned "Overweight" rating on Tuesday, January 30 by Morgan Stanley. FBR Capital has "Hold" rating and $8.0 target. See Globus Medical, Inc.

Total analysts of 2 have positions in Carrols Restaurant Group (NASDAQ:TAST) as follows: 2 rated it a "Buy", 0 with "Sell" and 0 with "Hold". The positive are 100%.

Analysts await Carrols Restaurant Group, Inc. TAST was included in 3 notes of analysts from November 20, 2017. The rating was downgraded by Raymond James on Tuesday, September 26 to "Outperform". On Monday, March 5 the company was maintained by Citigroup.

Jeffrey Bronchick decreased its stake in Carrols Restaurant Group Inc (TAST) by 4.63% based on its latest 2017Q4 regulatory filing with the SEC. The company has a market capitalization of $394.62, a P/E ratio of 67.50, a PEG ratio of 2.08 and a beta of 0.26.

During 2017 Q4 the big money sentiment increased to 1.24. It has change of 0.13, from 2017Q3's 1.11. 29 grew positions while 23 funds acquired positions. (NASDAQ:TAST) for 2,500 shares. (NASDAQ:TAST). Oppenheimer Asset Management accumulated 76,360 shs or 0.02% of the stock. Us National Bank De holds 0% in Carrols Restaurant Group, Inc. (NASDAQ:TAST) for 1.71M shares. (NASDAQ:TAST). Moreover, Cannell Cap Limited Liability Co has 6.03% invested in Carrols Restaurant Group, Inc. Citigroup owns 41,035 shares. Millennium Management LLC raised its position in shares of Carrols Restaurant Group by 679.3% during the fourth quarter. (NASDAQ:TAST). Sei Invs stated it has 157 shares. Art Advsrs Lc reported 0.01% stake. (NASDAQ:TAST). Ny State Common Retirement Fund holds 35,400 shares or 0% of its portfolio. Sg Americas Ltd Liability Corporation holds 0.02% of its portfolio in ONE Gas, Inc. (NASDAQ:TAST). 121,900 are owned by Bridgeway Cap Mngmt.

Zacks Investment Research Upgrades Noble Midstream Partners (NBLX) to Hold
The Manufacturers Life Insurance Company lifted its holdings in shares of EQT Midstream Partners by 49.6% during the 2nd quarter. Out of 2 Wall Street analysts rating Summit Midstream Partners, 1 give it "Buy", 0 "Sell" rating, while 1 recommend "Hold".

Royal Challengers Bangalore vs Delhi Daredevils
This is the first match for Virat Kohli's RCB after his team's humiliating 46-run loss to Mumbai Indians. Barring Rishabh Pant and Glenn Maxwell's return of form, there have been hardly any positives for Delhi.

Netflix (NFLX) Given New $330.00 Price Target at Raymond James
Loop Capital reiterated a "buy" rating and set a $237.00 target price on shares of Netflix in a report on Wednesday, December 6th. The Internet television network reported $0.64 EPS for the quarter, topping analysts' consensus estimates of $0.63 by $0.01.

Since December 14, 2017, it had 0 insider purchases, and 1 insider sale for $32,000 activity.

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The firm offers cell and animal physiology products, such as syringe pump and peristaltic pump products, as well as a range of instruments and accessories, including surgical products, infusion systems, microdialysis instruments, behavior research systems, and isolated organ and tissue bath systems, as well as in vivo and in vitro electrophysiology recording, stimulation, and analysis systems for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, Hugo-Sachs, InBreath Bioreactor, MCS, TBSI, and HEKA brands. It has a 46.27 P/E ratio. It provides fusion products that are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions.

The stock decreased 1.18% or $0.81 during the last trading session, reaching $67.62. About 363,983 shares traded. MFA Financial, Inc. (NYSE:MFA) has declined 4.79% since April 19, 2017 and is downtrending. It has outperformed by 53.81% the S&P500.

Investors sentiment increased to 1.32 in 2017 Q4. Its down 0.39, from 1.38 in 2017Q3. It is negative, as 26 investors sold Globus Medical, Inc. shares while 83 reduced holdings. State Board Of Administration Of Florida Retirement Sys reported 15,568 shares. It increased, as 15 investors sold ONE Gas, Inc. shares while 79 reduced holdings. Comm Bancorp has invested 0.01% in Globus Medical, Inc. (NYSE:GMED). Moreover, Swiss Bankshares has 0.01% invested in Globus Medical, Inc. (NYSE:GMED) for 123,300 shares. Gam Ag reported 37,371 shares. The Trafelet Brokaw Capital Management Lp holds 697,291 shares with $8.47M value, down from 813,163 last quarter. (NASDAQ:HBIO). First Manhattan Com has 131,000 shares. Weiss Multi holds 0.08% or 253,863 shares in its portfolio. Cove Street Capital Llc sold 80,077 shares as the company's stock declined 9.68% with the market. Bessemer Grp Inc Inc invested in 0% or 2,850 shares. (NYSE:MFA) for 38,351 shares.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by

Discuss This Article